Sv Health Investors, LLC Avrobio, Inc. Transaction History

Sv Health Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.84 - $12.6 $2.16 Million - $3.47 Million	-275,034 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $9.66 Million - $17.7 Million	-916,642 Reduced 76.92%	275,034 $3.49 Million
Q4 2020 Feb 16, 2021	SELL	$12.79 - $17.1 $568,477 - $760,043	-44,447 Reduced 3.6%	1,191,676 $16.6 Million
Q1 2020 May 15, 2020	SELL	$10.08 - $27.21 $1.83 Million - $4.93 Million	-181,081 Reduced 12.78%	1,236,123 $19.2 Million
Q3 2019 Nov 14, 2019	SELL	$14.12 - $23.44 $7.25 Million - $12 Million	-513,500 Reduced 26.6%	1,417,204 $20 Million
Q1 2019 May 15, 2019	SELL	$12.46 - $22.05 $10 Million - $17.8 Million	-805,323 Reduced 29.43%	1,930,704 $42.6 Million
Q2 2018 Aug 06, 2018	BUY	$28.08 - $31.2 $76.8 Million - $85.4 Million	2,736,027 New	2,736,027 $78.1 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Sv Health Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sv Health Investors, LLC with notifications on news.